SEC Form 4 · accession 0001623919-16-000027
EndoChoice Holdings, Inc. · GI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David N Gill
Officer — Chief Financial Officer
Period of report
Mar 7, 2016
Accepted (ET)
Mar 7, 2016 · 4:45 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001623919
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock, par value $0.001 per shareF1,F2 | Mar 7, 2016 | P | 5,000 | $4.77 | A | 23,130 | I | By David N. Gill & Dianne P. Gill Joint Living Trust |
| Common stock, par value $0.001 per shareF2,F3 | holding | — | — | — | 124,074 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging, inclusively, from $4.70 to $4.80 on purchases reported for March 7, 2016. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.
- F2From September 2015 to February 2016, the Reporting Person transferred 8,975 directly held shares into the David N. Gill & Diane P. Gill Joint Living Trust.
- F3The total direct shares shown includes 105,748 time-vesting restricted stock award shares.